Skip to : [Content] [Navigation]
 

Originally Published IVD Technology October 2004

Filters, membranes, and bioseparation equipment and supplies

Figure 1. A microporous cellulose nitrate membrane by Sartorius AG (Göttingen, Germany) is used as a lateral-flow membrane for diagnostic tests (click to enlarge).

Filters used by IVD manufacturers encompass both simple materials (e.g., cellulose paper for liquid absorption or clarification) and complex materials (e.g., membrane adsorbers for selective and quantitative retention of target molecules). Filters are important components in IVDs. They either are an inherent part of the device itself, such as in rapid tests, or provide clean and consistent reagents to build and run IVDs. To provide a better understanding of these materials, this article will review how filters are used in IVDs by listing their properties and functions. Developers, manufacturers, and users of IVDs will find this article helpful in choosing the right filters for specific applications.

Using Filters in IVDs
Reagent Production. Filters have become key materials for purifying, concentrating, and sterilizing reagents used in IVDs. They are also required for bioburden testing during reagent production.

A good example is the biotechnological process for producing monoclonal antibodies (MAB), a key component in many IVD instruments and rapid tests. MAB production starts in the lab, where the appropriate hybridoma cells are created and selected. At this stage, several filtration devices are used, from simple syringe filters to sophisticated multiwell plates with microporous membranes or ultrafilters. During production, cells are grown in bioreactors that are equipped with sterilizing filters. This is done to ensure the sterility of all incoming liquids and gases. Once the titer has reached its optimum level, the fermentation broth is centrifuged and clarified by using a microporous cross-flow system or a cellulose-based depth filter.

MABs are then separated from the clarified broth through either conventional bed chromatography or membrane adsorbers. Further purification, concentration, and final polishing are achieved with ultrafiltration and membrane flow-through devices, and extended by gel permeation chromatography. Such steps are needed to remove the remaining DNA, endotoxins, and large protein aggregates. Like most other reagents, MABs have already encountered many different filter media before being used in an IVD assay.

Operating Lab Analyzers. A standard test format in the IVD industry is the laboratory test instrument. Such instruments use reagents containing highly specific biological or chemical substances that react with the target analytes and generate a measurable response. The instruments bring such reagents into contact with defined sample volumes and measure the resulting change in property, such as a change in the sample’s color or fluorescence. Such tests are commonly performed on highly automated instruments in hospital labs, which cover the complete spectrum of IVDs (e.g., clinical chemistry, immunochemistry, hematology, microbiology, infectious immunology, and genetic testing).

Operating such test instruments increasingly involves separation filters in order to attain clean and consistent reagents that are free of particles and aggregates. Using such filters assures the constant quality of not only the reagents but also the rinsing and dilution water. Filter devices or cartridges are used directly inside the instruments.

Building Rapid Tests. Another standard test format is the rapid test. Such tests are performed on single-use strips, cassettes, or flow-through devices. Although rapid tests are not always faster than huge clinical analyzers, no instrumentation is needed to obtain the results.

In the IVD industry, membrane filters are most commonly used in rapid-test strips. Most rapid tests in lateral or flow-through format have a membrane filter at the heart of their strip assemblies. In fact, rapid tests would be more appropriately called “IFDs,” or “in-filter diagnostics,” since most of the main reactions between the different reagents and the sample take place inside a membrane filter.

Filter Types

The following descriptions of different filter types used in IVDs, along with the list of suppliers in the following pages, will help IVD manufacturers choose the appropriate filters for their particular applications. In general, the structure and surface chemistry of a filter determine its functionality and suitability for a specific task.

Filter Papers. Filter papers have a variety of different specifications regarding thickness, density, gloss, wicking speed, etc. Such papers are made of cellulose fibers that are randomly laid in a wet process and dried. They are extensively used in rapid tests as prefilters, wicking reservoirs, and support layers.

Nonwoven Filter Materials. Nonwoven filters are fabricated from synthetic fibers using methods (other than weaving, knitting, braiding, etc.) and processes such as dry or wet laying, chemical-, hot-, or spun-bonding, and needle punching. Nearly all types of fibers can be used to manufacture nonwoven materials (e.g., polyester, polyolefin, glass fibers) that are used as prefilters and conjugate pads. Since nonwoven filters represent many different structures, a supplier might have up to 70 product families that correspond to the various major applications. One subcategory is bonded fibers that form a nonwoven structure available in different shapes other than flat sheets. Such bonded-fiber materials are used as filters, liquid wicks, and other capillary transfer components to absorb, transfer, or release liquids in a more controlled manner.

Sintered Beads. Such materials are made by fusing spherical plastic beads. Different synthetic polymers, mainly polyolefins, are used. Similar to bonded-fiber materials, sintered-bead materials can be produced in nearly any shape due to the freedom that the process offers, which sometimes facilitates their automatic handling. The beads are used as filters, reservoirs, and wicks.

Microporous Membranes. Due to their tight pore-size distribution, membranes are commonly used as screen filters. This distinguishes them from the materials described above, which are referred to as depth filters. Membranes are produced through controlled polymer-precipitation processes that involve evaporation, solvent exchange, or thermally induced phase separation. Filtration applications of microporous membranes are well known, the most common of which is sterile filtration of liquids and gases.

Some small-pore-size polyethersulfone and polyamide membranes are used in rapid glucose strips. However, their volumes are decreasing as the market is moving toward electrochemical biosensors that do not use membranes. The most popular membrane used in IVDs is still the large-pore-size cellulose nitrate membrane in lateral-flow rapid tests. Its precise structure and highly adsorptive surface allow for rapid protein binding and easy flow of different reagents, including large latex conjugate particles (see Figure 1).

Ultrafiltration Membranes. If a membrane’s pores are small enough, the membrane not only retains particles but also holds back larger molecules. Ultrafiltration membranes are rated on the basis of nominal molecular weight cutoffs (NMWCO). For example, a 100-kilodalton (kD) membrane can concentrate and purify antibodies that have molecular weights greater than 150 kD. At the same time, proteins or peptides as small as 1 kD can be concentrated and desalted using ultrafilters with much lower NMWCOs. Such membranes are implemented in devices that operate under high pressures or in fast tangential flow to reduce fouling and concentration polarization. Because of this limitation, they are not used in rapid tests (see Figure 2).

Membrane Adsorbers. Standard microporous membranes undergo some surface-property changes. The most common changes turn the naturally hydrophobic polymer surface into a hydrophilic one to improve wettability. This is achieved by adding surfactant or a hydrophilic coating layer.

Today, further surface modifications may be accomplished by grafting specific groups onto the main polymeric backbone. The same chemistries that exist in chromatography gels (e.g., ion exchange) or reactive aldehyde and epoxy groups are then available on a membrane to selectively bind molecules in large quantities because of the large surface area. Membranes precoated with ligands such as metal chelates, protein A, and protein G are also available off the shelf. However, compared with chromatography beds, high flow rates can be obtained at moderate pressures due to the large pores and the membrane structure’s rigidity. Membrane adsorbers are derived from microporous membranes and exhibit a similar structure.

Choosing Suitable Materials

IVD manufacturers today have a wide choice of filter materials. One recommendation for selecting a filter material is to have a precise idea of what it should achieve. Manufacturers should work with their filter suppliers to get a clear idea of the relation between the material’s characteristics that are given on the supplier specifications sheet and the expected performance of the test, such as sensitivity, specificity, signal intensity, etc. This can be the starting point for a focused selection of filters that are used for a first round of performance testing.

New Frontiers for Rapid Tests

Figure 1. A microporous cellulose nitrate membrane by Sartorius AG (Göttingen, Germany) is used as a lateral-flow membrane for diagnostic tests (click to enlarge).

While rapid tests represent a small share of the more than $22 billion worldwide IVD market, they are the major market for membrane filters. Filter manufacturers as well as filter users should pay attention to the current challenges that the rapid-test industry is facing.

Increasing Need for Quantitative Results. In general, rapid tests exhibit impressive sensitivity along with low cost and ease of use.
For example, a standard pregnancy strip can detect down to 5 mIU of hCG hormone and costs only a few cents to manufacture. Other tests might exhibit even higher sensitivity. An experimental test by Sartorius AG (Göttingen, Germany) exploits a silver enhancement method and can detect 50 pg/ml of botulinum toxin type D. In other words, a simple strip using 150 µl of sample can detect 10–12 g of the toxin.

However, rapid tests do have a major limitation: they deliver only qualitative results. Because a “yes” or “no” answer detected by the human eye is often unsatisfactory, IVD manufacturers have been developing rapid tests that deliver quantitative results, some of which are being commercialized with some success. The most common readers translate line intensity into analyte concentration, and use either colorimetric reflectance or a CCD camera to measure the signal intensity. Other commercially available readers use the emittance of a fluorescent label that is fixed to conjugate particles. A magnetic reader for detecting paramagnetic beads was recently introduced. Different manufacturers are also developing many other technologies.

Depending on the technology, the particular signal that is emitted from a marker determines to what depth within the membrane a marker will contribute to the overall signal. As used in colorimetric or fluorescent techniques, visible light is scattered by the membrane structure and will only contribute when situated in the top 20–30 µm of the membrane. However, magnetic signals penetrate the membrane structure more easily and will be less attenuated, giving an integrated, more accurate signal of the total amount of marker captured in a test line.

While there is a clear goal for IVD manufacturers to develop rapid tests with reliable quantification, it is not only up to them to reach that goal. For example, producing lateral-flow membranes that are at the heart of any rapid test and act as a sophisticated solid-phase substrate and liquid-delivery system puts high demands on membrane suppliers with respect to membrane quality and consistency. To get a quantitative signal on a lateral test, all strip components need to behave in a quantitative manner (i.e., they need to be produced within tight specifications to deliver the required reproducibility).

Race for New Markers. Pregnancy tests and glucose strips have long dominated the rapid-test market in terms of sales volume. New markers, though, are needed to open up new opportunities. Recent discussions among scientists indicated that the difficulty in finding new single markers might be due to the genetic heterogeneity among populations. In other words, testing for one single marker may no longer be sufficient. Tests need to contain a larger panel of markers to detect only one specific disease or metabolic function.

To test large panels of analytes in one device with one sample is a challenge for rapid-test manufacturers and their suppliers. Microarrays might play a role in defining such new test formats. Today, most microarray slides are still made of surface-treated glass. However, filters and especially membranes are already contributing to higher-sensitivity arrays due to their 3-D structure, giving increased binding capacity at the same footprint.

The saying, “Nice things come in small packages,” is not the only current paradigm in this market. Other needs propelling the development of the clinical market are workflows with instruments and materials that enable parallel tasking as well as quantitative output.

Eric Jallerat and Volkmar Thom, Sartorius AG (Göttingen, Germany) 

Copyright ©2004 IVD Technology